In February 2018, the FDA and CDC approved the recommendation for a new hepatitis B vaccine, Heplisav-B targeting adults over the age of 18. The U.S. Food and Drug Administration (FDA) had twice rejected the application for licensure for Heplisav-B in the past four years because of safety signals. Heplisav-B differs from other licensed hepatitis B vaccines in that it contains a new synthetic adjuvant known as cytosine phosphoguanine 1018 (CpG 1018) composed of short synthetic DNA molecules. In 2016, the FDA rejected an application for licensure for the Heplisav-B vaccine, because the agency was concerned about an increased rate of heart attacks and deaths in people who had been given the vaccine. During the trial, approximately 14 subjects had heart attacks. In July 2017, the FDA committee convened to re-evaluate the scientific evidence and make a decision on whether Heplisav B should or should not be approved for use in the U.S. This committee had only one cardiologist on the team, Milton Packer, MD, who is a distinguished scholar in cardiovascular science at the Baylor University Medical Center in Dallas, Texas. According to Dr. Packer, it was possible that the Heplisav B vaccine’s novel adjuvant was related to the higher number of heart attacks in study participants who received the experimental vaccine. He stated: “To know if the 7 -1 heart attack imbalance represented a real risk, we’d need comparative data in 50,000 people.” However, the only way to conduct such a large trial would be to approve the vaccine and see what happens in the public. With Dr. Packer abstaining in his vote to recommend the vaccine, the FDA committee approved it anyway. Dr. Packer stated: “Why did I abstain? Based on the available data, it was impossible for anyone to know if the increase in heart attack risk was real. There is a simple rule in life: if you don’t know, you should say you don’t know.” The vaccine is now available to the public, and all those who receive it are basically guinea pigs to find out if heart attacks will result from the experimental vaccine, and if it will continue to have FDA approval.
[Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Study on combining Aluminum with 1018 (CPG1018 as above)
Study: Cytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid
Statement by Erdem I. Cantekin, PhD of University of Pittsburgh’s School of Medicine sent as an open letter to The Journal of the American Medical Association (JAMA):
There is no scientific evidence to justify HBV vaccination before the age when those risk factors associated with the HBV transmission (sex, needles, etc.) become relevant. Recent risk-benefit analysis show HBV vaccination among children carries one of the largest unjustified risks and substantial financial costs, second only to the new controversial conjugate pneumococcal vaccine. (Emphasis added).
The Hepatitis B, or Hep-B (HBV) vaccination has been traced as the source of Sudden Infant Death Syndrome (SIDS) on hundreds of occasions. So what to do if a hospital pediatrician threatens to take your newborn baby from you if you reject the Hep-B vaccination?
After noticing that neither parent had been tested for hepatitis B recently, Dr. Bierd decided to overrule the parents’ Hep-B vaccination refusal by invoking “doctor discretion” to override the parent’s refusal, a policy that’s valid only in life or death emergencies.Read story…
In the US, the Hepatitis B disease mainly infects intravenous drug users, homosexuals, prostitutes and promiscuous heterosexuals. The disease is transmitted by blood, through sex or dirty needles. How could a newborn baby possibly get Hepatitis B if the mother doesn’t have it? New borns are injected with Hep B at 1-12 hours old and sometimes the hospitals don’t get permission from the parents. Be sure to submit upon your arrival at the hospital to give birth, a statement of record that you do not want your baby to be injected with any vaccines including but not limited to Hep B. DO NOT inject your baby with vaccines until you have done due diligence. Breast feeding, organic food will be sufficient protection until you do your research. So hold off.
Lyla Rose Belkin was a lively, alert five-week-old baby when I last held her in my arms. Little did I imagine as she gazed intently into my eyes with all the innocence and wonder of a newborn child that she would die that night. Read more…
Study by Rajeev Kumar & Jacob Puliyel, Head of Pediatrics,St Stephens Hospital Delhi 110054
Read study….open access
Three salient points emerge from their study. Here are two:
1. Authors found that vaccination did not reduce hepatitis B carrier rate, which is the primary aim of the immunization program.
2. At 6 years of age, protective levels of anti-HBs antibody (10 mlU/mL) were present only in about 59% of those immunized. By 11 years, only 13% had protective levels. Read more…
Comparable to world literature, that without vaccination, a third of the population get infected and the vast majority clear the infection.
Watch this 10 minute presentation from Think Twice on Hepatitis B vaccine
Watch this presentation on “overdosed babies”.